Becton, Dickinson and Company BDX

183.82 4.59 2.56% as of 25 Sep
Market cap
$48.8B
P/E
55.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Becton, Dickinson and Company (BDX) Debt to equity

Becton, Dickinson and Company's debt to equity at the end of the quarter to 30 June 2026 was 0.6×, down 0.1× from fiscal 2025 (0.7×). Over the past ten years it has ranged from 0.5× (fiscal 2022) to 1.6× (fiscal 2015); the current reading is higher than 36% of that period. That is above the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Annual

Period Debt to equity Change
FY2025 0.7× 0.16%
FY2024 0.7× 21.28%
FY2023 0.6× 4.02%
FY2022 0.5× (24.00%)
FY2021 0.7× (0.30%)
FY2020 0.7× (15.49%)
FY2019 0.9× (4.70%)
FY2018 0.9× (37.57%)
FY2017 1.4× 4.30%
FY2016 1.4× (12.91%)

Quarterly

Period Debt to equity Change
Jun 2026 0.6× (9.19%)
Mar 2026 0.6× (8.92%)
Dec 2025 0.7× (3.59%)
Sep 2025 0.7× 0.84%
42 more quarters

Against its own ten years

Low 0.5× High 1.6×
Ten-year median 0.7×
Current reading's percentile 36

Debt to equity against peers

Company Debt to equity
ISRG Intuitive Surgical, Inc. compare 0.0×
RMD ResMed Inc. compare 0.1×
WST West Pharmaceutical Services, Inc. compare 0.1×
ALC Alcon compare 0.2×
RGEN Repligen Corporation compare 0.3×
BDX Becton, Dickinson and Company 0.6×
MDLN Medline Inc. compare 0.7×
SOLV Solventum Corporation compare 1.1×
BAX Baxter International Inc. compare 1.5×
Medical Instruments & Supplies industry median 0.1×
Healthcare sector median 0.0×
Market median 0.2×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on BDX